Key Client Fiduciary Advisors, LLC Cytosorbents Corp Transaction History
Key Client Fiduciary Advisors, LLC
- $203 Million
- Q4 2024
A detailed history of Key Client Fiduciary Advisors, LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Key Client Fiduciary Advisors, LLC holds 34,557 shares of CTSO stock, worth $39,740. This represents 0.02% of its overall portfolio holdings.
Number of Shares
34,557
Previous 34,557
-0.0%
Holding current value
$39,740
Previous $51,000
39.22%
% of portfolio
0.02%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding CTSO
# of Institutions
58Shares Held
15.7MCall Options Held
16KPut Options Held
0-
Avenir Corp Washington, DC3.09MShares$3.56 Million0.29% of portfolio
-
Skylands Capital, LLC2.78MShares$3.2 Million0.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$2.24 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$1.93 Million0.0% of portfolio
-
Sargent Investment Group, LLC1.25MShares$1.44 Million0.18% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $50.1M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...